Literature DB >> 26285044

Group B Streptococci serotype distribution in pregnant women in Ghana: assessment of potential coverage through future vaccines.

C D Vinnemeier1,2, P Brust2, E Owusu-Dabo3, N Sarpong4, E Y Sarfo5, Y Bio6, T Rolling1,2, D Dekker4, Y Adu-Sarkodie7, K A Eberhardt2, J May4, J P Cramer1,2.   

Abstract

OBJECTIVE: Group B streptococcal (GBS) colonization of pregnant women can lead to subsequent infection of the new-born and potentially fatal invasive disease. Data on GBS colonization prevalence and serotype distribution from Africa are scarce, although GBS-related infections are estimated to contribute substantially to infant mortality. In recent years, GBS vaccine candidates provided promising results in phase I and II clinical trials. We aimed to assess the prevalence and serotype distribution of GBS in Ghana since this knowledge is a prerequisite for future evaluation of vaccine trials.
METHODS: This double-centre study was conducted in one rural and one urban hospital in central Ghana, West Africa. Women in late pregnancy (≥35 weeks of gestation) attending the antenatal care clinic (ANC) provided recto-vaginal swabs for GBS testing. GBS isolates were analysed for serotype and antibiotic susceptibility. GBS-positive women were treated with intrapartum antibiotic prophylaxis (IAP) according to current guidelines of the Center for Disease Control and Prevention (CDC).
RESULTS: In total, 519 women were recruited at both study sites, recto-vaginal swabs were taken from 509. The overall prevalence of GBS was 19.1% (18.1% in rural Pramso and 23.1% in urban Kumasi, restrospectively). Capsular polysaccharide serotype (CPS) Ia accounted for the most frequent serotype beyond all isolates (28.1%), followed by serotype V (27.1%) and III (21.9%). No resistance to Penicillin was found, resistances to second line antibiotics clindamycin and erythromycin were 3.1% and 1%, respectively. DISCUSSION: Group B Streptococcus serotype distribution in Ghana is similar to that worldwide, but variations in prevalence of certain serotypes between the urban and rural study site were high. Antibiotic resistance of GBS strains was surprisingly low in this study.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990EGBzzm321990; zzm321990SGBzzm321990; Africa; Afrique; Estreptococo Grupo B; Group B Streptococcus; Streptococcus du groupe B; femmes enceintes; mujeres embarazadas; pregnant women; septicaemia; septicemia; septicémie; vaccine; África

Year:  2015        PMID: 26285044     DOI: 10.1111/tmi.12589

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  4 in total

Review 1.  Group B Streptococcus (Streptococcus agalactiae).

Authors:  Vanessa N Raabe; Andi L Shane
Journal:  Microbiol Spectr       Date:  2019-03

2.  Carriage and serotype distribution of Streptococcus agalactiae in third trimester pregnancy in southern Ghana.

Authors:  Hans-Christian Slotved; Nicholas T K D Dayie; Josephine A N Banini; Niels Frimodt-Møller
Journal:  BMC Pregnancy Childbirth       Date:  2017-07-21       Impact factor: 3.007

3.  Evaluation of procedures for typing of group B Streptococcus: a retrospective study.

Authors:  Hans-Christian Slotved; Steen Hoffmann
Journal:  PeerJ       Date:  2017-03-16       Impact factor: 2.984

Review 4.  Group B Streptococcal Colonization in African Countries: Prevalence, Capsular Serotypes, and Molecular Sequence Types.

Authors:  Sarah Shabayek; Patricia Ferrieri; Barbara Spellerberg
Journal:  Pathogens       Date:  2021-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.